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Summary
The AGC family serine–threonine kinases Akt and Sgk are similar
in primary amino acid sequence and in vitro substrate specificity,
and both kinases are thought to directly phosphorylate and
inhibit FoxO transcription factors. In the nematode Caenorhabd-
itis elegans, it is well established that AKT-1 controls dauer arrest
and lifespan by regulating the subcellular localization of the
FoxO transcription factor DAF-16. SGK-1 is thought to act
similarly to AKT-1 in lifespan control by phosphorylating and
inhibiting the nuclear translocation of DAF-16/FoxO. Using sgk-1
null and gain-of-function mutants, we now provide multiple lines
of evidence indicating that AKT-1 and SGK-1 influence C. elegans
lifespan, stress resistance, and DAF-16/FoxO activity in funda-
mentally different ways. Whereas AKT-1 shortens lifespan, SGK-1
promotes longevity in a DAF-16-/FoxO-dependent manner. In
contrast to AKT-1, which reduces resistance to multiple stresses,
SGK-1 promotes resistance to oxidative stress and ultraviolet
radiation but inhibits thermotolerance. Analysis of several
DAF-16/FoxO target genes that are repressed by AKT-1 reveals
that SGK-1 represses a subset of these genes while having little
influence on the expression of others. Accordingly, unlike AKT-1,
which promotes the cytoplasmic sequestration of DAF-16/FoxO,
SGK-1 does not influence DAF-16/FoxO subcellular localization.
Thus, in spite of their similar in vitro substrate specificities, Akt
and Sgk influence longevity, stress resistance, and FoxO activity
through distinct mechanisms in vivo. Our findings highlight the
need for a re-evaluation of current paradigms of FoxO regulation
by Sgk.
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Introduction
Akt/protein kinase B (PKB) and Sgk are two highly related members of
the AGC family of serine–threonine kinases that act in cellular signaling
pathways to modulate survival, growth, proliferation, metabolism, and
other processes (Pearce et al., 2010). Akt/PKB has evolutionarily
conserved functions in the control of development, growth, metabolism,
cell survival, and longevity, and dysregulation of Akt/PKB contributes to
the pathogenesis of common human diseases such as cancer and type 2
diabetes (Franke, 2008).
The mechanism of Akt/PKB activation is well established. In response
to growth factors, Akt/PKB is activated in a phosphoinositide 3-kinase
(PI3K)-dependent manner by phosphorylation at two critical regulatory
sites: T308 within its kinase domain and S473 within a C-terminal
hydrophobic motif (Alessi et al., 1996a). The 3-phosphoinositide-
dependent kinase PDK1 phosphorylates Akt/PKB at T308 (Alessi et al.,
1997; Stephens et al., 1998), and members of the PI3K-related kinase
(PIKK) family such as TOR complex 2 phosphorylate Akt/PKB at S473
(Feng et al., 2004; Sarbassov et al., 2005; Viniegra et al., 2005).
Activated Akt/PKB phosphorylates several substrates in vivo at sites
that lie within RxRxxS/T motifs (Alessi et al., 1996b; Manning & Cantley,
2007). Among these substrates are the FoxO family of transcription
factors that control development, metabolism, growth, and aging
(Accili & Arden, 2004). Akt/PKB-dependent phosphorylation of FoxO at
three conserved RxRxxS/T motifs inhibits FoxO activity by promoting its
export from the nucleus and sequestration in the cytoplasm (Brunet
et al., 1999). FoxO is a critical substrate of Akt/PKB in vivo, as its
disinhibition in mice with reduced hepatic Akt/PKB signaling impairs
metabolic homeostasis (Dong et al., 2008), and a null mutation in daf-
16, which encodes the sole FoxO transcription factor in the nematode
Caenorhabditis elegans, suppresses the dauer-constitutive and lifespan
extension phenotypes of animals with reduced Akt/PKB activity (Paradis
& Ruvkun, 1998; Kwon et al., 2010). Thus, Akt/PKB has an
evolutionarily conserved function as a direct inhibitor of FoxO
transcription factors.
The serum- and glucocorticoid-regulated kinase gene sgk encodes a
serine–threonine kinase highly homologous to Akt/PKB that was first
identified as a gene whose transcription is induced acutely by serum and
glucocorticoids in a rat mammary tumor cell line (Webster et al., 1993).
Like Akt/PKB activation, Sgk activation by growth factors is PI3K
dependent and involves the phosphorylation of a site in the kinase
domain (T256) by PDK1 (Kobayashi & Cohen, 1999; Park et al., 1999)
and a C-terminal site within a hydrophobic motif by TOR complex 2
(Garcia-Martinez & Alessi, 2008). Furthermore, Sgk also phosphorylates
sites that lie within RxRxxS/T motifs (Kobayashi & Cohen, 1999). In spite
of these similarities, some Akt/PKB substrates are poor substrates for Sgk
in vitro and vice versa (Murray et al., 2004a,b); this is likely due at least in
part to amino acids in the vicinity of the phosphoacceptor residue that
confer substrate specificity (Murray et al., 2005). The distinct substrate
specificities of Akt/PKB and Sgk are reflected in the observation that
although both mammalian Akt/PKB and Sgk can promote the phos-
phorylation of the FoxO3 transcription factor in cultured cells at sites
within all three conserved RxRxxS/T motifs, they do so with distinct
efficiencies within each motif (Brunet et al., 2001).
In mammalian cell culture, Sgk inhibits FoxO3 activity (Liu et al.,
2000; Brunet et al., 2001), and in C. elegans, SGK-1 is thought to limit
lifespan by inhibiting DAF-16/FoxO activity (Hertweck et al., 2004).
Taken together with the known role of Akt/PKB in FoxO regulation,
these studies have established a paradigm whereby Akt/PKB and Sgk are
thought to act via similar mechanisms to inhibit FoxO activity (Fielenbach
& Antebi, 2008; Bruhn et al., 2010; Pearce et al., 2010).
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We and others recently reported that in contrast to the lifespan
extension phenotype observed after RNAi knockdown of sgk-1 (Hert-
weck et al., 2004), sgk-1 null mutations shorten C. elegans lifespan
(Soukas et al., 2009; Alam et al., 2010; Kwon et al., 2010). This
phenotype is the opposite of that observed for akt-1 null mutations
(Soukas et al., 2009; Alam et al., 2010; Kwon et al., 2010) and is
inconsistent with prevailing models implicating Sgk as a FoxO inhibitor.
In light of these results, we have performed a detailed phenotypic
analysis of sgk-1 null and gain-of-function mutants. Our results indicate
that in C. elegans, Akt/PKB and Sgk influence lifespan, stress resistance,
and FoxO transcription factor activity through distinct mechanisms.
These surprising findings call into question current paradigms of FoxO
regulation by Sgk and reveal that the interaction between Sgk and FoxO
transcription factors may be more complex than previously appreciated.
Results
Effects of sgk-1 mutations on lifespan
We and others have shown that the sgk-1(mg455) mutation shortens
lifespan (Soukas et al., 2009; Alam et al., 2010). The mg455 allele is a
nonsensemutation that is predicted to result in truncation of SGK-1within
its kinase domain (Soukas et al., 2009); therefore, this is likely to be a null
mutation. A third group has shown that the sgk-1(ok538) deletion
mutation, which is predicted to remove half of the SGK-1 kinase domain
and is also probably a null mutation (Hertweck et al., 2004), also reduces
lifespan (Kwon et al., 2010). We confirmed these results by measuring the
lifespans of both sgk-1(ok538) and sgk-1(mg455) null mutants in the same
assay (Fig. 1BandTableS1). sgk-1(ok538) (heretofore referred toas ‘null #1’)
and sgk-1(mg455) (heretofore referred to as ‘null #2’) each shorten mean
lifespan by at least 27.5% and median lifespan by at least 19.0% and
33.3%, respectively (P < 0.0001 by the log-rank test). The observation
that two outcrossed strains harboring independently isolated sgk-1 null
mutations both have short lifespans compared with wild-type animals
strongly suggests that these short lifespan phenotypes are a consequence
of reduced SGK-1 activity. These results contrastwith the reported lifespan
extension induced by sgk-1 RNAi (Hertweck et al., 2004) and are
consistent with a model whereby SGK-1 promotes longevity.
One possible explanation for the discrepancy between the lifespans of
animals harboring sgk-1 loss-of-function mutations and animals sub-
jected to sgk-1 RNAi is that strong loss-of-function mutations could
cause developmental abnormalities that shorten adult lifespan by reduc-
ing general fitness; such abnormalities can be avoided by initiating RNAi
during late larval or early adult stages. To address this possibility,
we assayed the lifespans of animals harboring the sgk-1(ft15)
gain-of-function mutation.
(A)
(B) (C)
(D)
(F)
(E)
Fig. 1 Effects of sgk-1 mutations on
lifespan. (A) Schematic of the sgk-1
genomic locus (not to scale). Locations of
the ft15 missense gain-of-function, ok538
deletion, and mg455 nonsense mutations
are shown. Exons encoding the kinase
domain are colored red. (B) Lifespans of
sgk-1 mutants ft15 (gf), ok538 (null #1),
and mg455 (null #2). (C) Effect of the daf-
16(mu86) null mutation on the lifespans of
sgk-1(gf) animals. (D) Effect of sgk-1(gf) on
the lifespan of akt-1(mg306) null mutant
animals. (E) Effect of sgk-1(gf) on the
lifespan of hcf-1(pk924) null mutant
animals. Raw data and statistics are
presented in Table S1.
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sgk-1(ft15) emerged from a genetic screen for suppressors of the
developmental delay phenotype of animals harboring a loss-of-function
mutation in lpo-6/rict-1, which encodes the C. elegans ortholog of the
TOR complex 2 component Rictor (Jones et al., 2009; Soukas et al.,
2009). sgk-1(ft15) suppresses both the developmental delay and small
body size phenotypes of lpo-6/rict-1 loss-of-function mutants, and this
suppression is abrogated by sgk-1 RNAi (Jones et al., 2009). Taken
together with the observations that lpo-6/rict-1 and sgk-1 act in the
same genetic pathway (Jones et al., 2009; Soukas et al., 2009) and
mammalian TOR complex 2 activates Sgk by promoting its phosphor-
ylation (Garcia-Martinez & Alessi, 2008), these data strongly suggest that
sgk-1(ft15) is a gain-of-function allele.
We reasoned that if sgk-1 null mutants are short-lived because SGK-1
plays a role in promoting longevity, then animals harboring sgk-1(ft15)
(heretofore referred to as ‘sgk-1(gf)’) should live longer than animals
with wild-type sgk-1. However, if sgk-1 null mutants are short-lived
because they are sick, then sgk-1(gf) animals would not be expected to
live long. sgk-1(gf) animals consistently lived ~ 15–20% longer than
nonsibling wild-type animals (Table S1B). When siblings harboring wild-
type sgk-1 were used as controls, sgk-1(gf) animals exhibited a more
modest but statistically significant extension in median and mean
lifespan in eight of ten experimental trials (Fig. 1B–E and Tables S1A,C).
In Fig. 1B, sgk-1(gf) increased mean and median lifespan by 17.5% and
9.5%, respectively, compared with wild-type siblings (P = 0.0008). This
lifespan extension was suppressed by a null mutation in daf-16/FoxO
(Fig. 1C and Table S1A).
In C. elegans, DAF-16/FoxO activity is regulated through at least two
mechanisms. Phosphorylation of DAF-16/FoxO by kinases such as
AKT-1 inhibits DAF-16/FoxO by promoting its export from the nucleus
(Lin et al., 2001; Zhang et al., 2008; Alam et al., 2010; Dumas et al.,
2010; Kwon et al., 2010). Other regulatory proteins such as HCF-1 and
EAK-7 inhibit DAF-16/FoxO activity without influencing its subcellular
localization (Li et al., 2008; Alam et al., 2010). To determine whether
SGK-1 acts specifically in either of these pathways to promote
longevity, we tested the effect of sgk-1 mutations on the lifespans
of akt-1 and hcf-1 null mutants. We previously reported that SGK-1 is
required for the longevity of akt-1 mutants (Alam et al., 2010). sgk-1
(gf) did not extend the lifespan of akt-1(null) animals (Fig. 1D and
Table S1A). Similarly, in hcf-1(null) animals, sgk-1 was required for
lifespan extension, but sgk-1(gf) did not further increase lifespan
(Fig. 1E and Table S1A). Based on these data, whether SGK-1 acts
specifically with AKT-1 or HCF-1 to influence lifespan is not clear. It is
possible that DAF-16/FoxO activation by SGK-1 is attenuated in
backgrounds such as akt-1(null) and hcf-1(null) in which DAF-16/FoxO
is already activated.
As the Escherichia coli HB101-derived HT115 strain used in experi-
ments demonstrating that sgk-1 RNAi extends lifespan (Hertweck et al.,
2004) differs from the OP50 strain used in our experiments (Fig. 1B–E),
we sought to determine the influence of E. coli strain differences on the
lifespans of sgk-1 mutants. Therefore, we assayed the lifespans of sgk-1
(null) and sgk-1(gf) mutants grown on HT115. As observed in experi-
ments using OP50 as a food source, sgk-1(null) shortened and sgk-1(gf)
extended lifespan in animals feeding on either HT115 or HB101 (Fig. 1F
and Table S1C). Therefore, the prolongevity activity of SGK-1 is not
significantly influenced by differences between E. coli OP50 and HT115/
HB101.
Taken together, these results suggest that in contrast to existing
paradigms of FoxO inhibition by Sgk (Brunet et al., 2001; Hertweck
et al., 2004), SGK-1 promotes C. elegans longevity in a DAF-16/FoxO-
dependent manner.
Effects of sgk-1 mutations on dauer arrest
Because DAF-16/FoxO promotes developmental arrest in the dauer larval
stage in animals with reduced DAF-2 insulin-like signaling (Vowels &
Thomas, 1992; Gottlieb & Ruvkun, 1994), we tested the effect of sgk-1
(null) and sgk-1(gf) on dauer arrest. In agreement with a previous report
(Hertweck et al., 2004), neither sgk-1(null) nor sgk-1(gf) had significant
effects on dauer arrest at 27°C (Table 1A). Although a significant
percentage of sgk-1(null) animals arrested during larval development
(Table 1A), analysis of these animals using Nomarski microscopy revealed
no evidence of dauer alae or pharyngeal constriction (Fig. S3), indicating
that these animals were nondauer larvae. In contrast and as previously
reported (Hu et al., 2006), an akt-1 null mutation had a strongly
penetrant DAF-16/FoxO-dependent dauer-constitutive phenotype
under the same assay conditions. Neither sgk-1(null) nor sgk-1(gf)
significantly influenced the dauer-constitutive phenotype of daf-2
(e1368) (Table 1B). Therefore, SGK-1 does not function in dauer
regulation.
Effects of sgk-1 mutations on stress resistance
In light of our observations on the effects of sgk-1 mutations on lifespan
(Fig. 1), we tested sgk-1(null) and sgk-1(gf) for their sensitivity to
oxidative stress, ultraviolet radiation (UVR), and heat. akt-1 null mutants
were slightly more resistant to hydrogen peroxide than wild-type
animals, although this difference was only statistically significant in
one of four assays (Fig. 2A,B and Table S2). akt-1 null mutants were
significantly more resistant to UVR and heat than wild-type animals
(Fig. 2C–F and Tables S3 and S4). In contrast, both sgk-1 null mutants
were more sensitive to hydrogen peroxide (statistically significant in 2 of
3 trials for each mutant) and UVR (statistically significant in 3 of 3 trials)
than wild-type animals (Fig. 2A,C and Tables S3–4), consistent with their
short lifespans (Fig. 1B and Table S1). sgk-1(gf) did not significantly
influence sensitivity to any of the three stressors tested (Fig. 2B,D,F and
Tables S3–5).
Both sgk-1 null mutations enhanced thermotolerance to at least the
same extent that an akt-1 null mutation did (Fig. 2E and Table S4). This
result is consistent with a previous report examining thermotolerance of
the sgk-1(ok538) null mutant (Hertweck et al., 2004). Taken together
with our observation that the sgk-1(gf) mutation extends lifespan (Fig. 1
and Table S1), this enhanced thermotolerance phenotype of sgk-1 null
mutants strengthens the argument that the short-lived phenotype of
sgk-1 null mutants is not simply a consequence of frailty secondary to
developmental abnormalities. In contrast to AKT-1, which promotes
general sensitivity to environmental stress, SGK-1 is protective against
oxidative stress and UVR but enhances sensitivity to heat.
As the thermotolerance of sgk-1(ok538) is thought to require DAF-16/
FoxO (Hertweck et al., 2004), we tested the effect of a daf-16 null
mutation on the thermotolerance of both sgk-1 null mutants. Surpris-
ingly, daf-16 null mutation did not significantly influence the thermotol-
erance of either sgk-1 null mutant (Fig. 2G and Table S4). Therefore, our
results suggest that SGK-1 promotes sensitivity to heat in a DAF-16/
FoxO-independent manner.
Effects of sgk-1 mutations on DAF-16A::GFP subcellular
localization
As our lifespan data are consistent with a model in which SGK-1
promotes longevity by activating DAF-16/FoxO, we sought to determine
the influence of sgk-1 mutations on the subcellular localization of
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DAF-16/FoxO. Sgk promotes the nuclear export and cytoplasmic
sequestration of FoxO in mammalian cells (Brunet et al., 2001);
however, based on conflicting reports in the literature (Hertweck et al.,
2004; Kwon et al., 2010), the role of C. elegans SGK-1 in regulating
DAF-16/FoxO localization remains unclear. We constructed sgk-1(null)
and sgk-1(gf) strains expressing a functional DAF-16A::GFP fusion
protein as the sole source of DAF-16/FoxO in the animal and determined
DAF-16A::GFP subcellular localization in young adult animals raised in
the same conditions used for lifespan assays (Fig. 3A and Table S5).
Under these conditions, akt-1 null mutation promoted the translocation
of DAF-16A::GFP from the cytoplasm to the nucleus, as previously
shown (Zhang et al., 2008; Alam et al., 2010; Dumas et al., 2010).
Neither the sgk-1(ok538) null mutation nor sgk-1(gf) had a significant
influence on the nucleocytoplasmic distribution of DAF-16A::GFP. These
data suggest that unlike AKT-1, SGK-1 does not control DAF-16/FoxO
activity in vivo by regulating its subcellular localization.
Effects of sgk-1 mutations on DAF-16/FoxO target gene
expression
The dependence of sgk-1(gf) lifespan extension on daf-16/FoxO (Fig. 1C)
suggests that SGK-1 may increase lifespan by activating DAF-16/FoxO,
even in the absence of a significant effect on DAF-16A::GFP localization
(Fig. 3A). Therefore, we quantified the expression of five DAF-16/FoxO
target genes (Murphy et al., 2003; Oh et al., 2006; Alam et al., 2010;
Dumas et al., 2010; Kwon et al., 2010) in young adult sgk-1(null) and
sgk-1(gf) animals (Fig. 3B–F and Table S6).
As expected for bona fide DAF-16/FoxO target genes, the expression
of all five of these genes is increased in a DAF-16/FoxO-dependent
manner in the context of akt-1 null mutation (Fig. 3B–F and Table S6)
(Alam et al., 2010; Dumas et al., 2010). In contrast, sgk-1mutations had
varying influences on the expression of these five genes. sod-3 expression
was not influenced by sgk-1(gf) but was reduced in sgk-1 null mutants
(Fig. 3B and Table S6). Thus, null mutations in sgk-1 and akt-1
have opposite effects on sod-3 expression. Neither sgk-1 null mutation
nor sgk-1(gf) reproducibly influenced the expression of nnt-1 and sip-1
(Fig. 3C,D and Table S6). Expression of both dod-3 andmtl-1was elevated
in a DAF-16/FoxO-dependentmanner in the context of sgk-1 null mutation
infiveof six trials (Fig. 3E,F andTable S6), suggesting that SGK-1andAKT-1
may act similarly to regulate these two DAF-16/FoxO target genes.
Inaggregate, thesedata indicate thatAKT-1andSGK-1controlDAF-16/
FoxO target gene expression through distinct mechanisms. The heteroge-
neity of the influence of sgk-1 mutations on DAF-16/FoxO target gene
expression suggests that the molecular basis for SGK-1 regulation of
DAF-16/FoxO activity is significantly more complex than has been
appreciated.
Discussion
Akt/PKB inhibits FoxO transcription factors via a well-established and
evolutionarily conserved mechanism involving phosphorylation of FoxO
at three sites that lie within conserved RxRxxS/T motifs (Manning &
Cantley, 2007; Franke, 2008). Based on both its similarity in primary
structure (Webster et al., 1993) and substrate specificity (Kobayashi &
Table 1 Effects of sgk-1mutations on dauer arrest. (A) Dauer formation of sgk-1 and akt-1mutants at 27°C. (B) Effect of sgk-1mutations on daf-2(e1368) dauer formation
at 25°C. Siblings were used in each experiment
Genotype
Trial 1 Trial 2 Trial 3 Average (SD)
N% Dauer
% Non-dauer
larvae % Dauer
% Non-dauer
larvae % Dauer
% Non-dauer
larvae % Dauer
% Non-dauer
larvae
(A) Effects of sgk-1 and akt-1 mutations on dauer formation at 27°C
Wild-type 0.0 0.0 0.0 0.0 0.0 2.3 0 (0) 0.8 (1.3) 991
akt-1(null) 97.7 0.6 94.5 5.0 89.1 10.9 93.8 (4.3) 5.5 (5.2) 705
daf-16(null);akt-l 0.0 1.8 0.0 9.3 0.0 15.2 0 (0) 8.8 (6.7) 811
sgk-l(gf) 0.0 0.0 0.0 0.0 0.0 10.3 0 (0) 3.4 (5.9) 968
daf-16;sgk-1(gf) 0.0 0.3 0.0 1.9 0.0 23.6 0 (0) 8.6 (13.0) 893
sgk-l(null) #1 0.0 26.7 0.0 52.8 0.0 90.0 0 (0) 56.5 (31.8) 1144
sgk-l(null) #2 0.0 67.5 0.0 46.5 0.0 91.8 0 (0) 68.6 (22.6) 1087
Genotype
Trial 1
% Dauer
Trial 2
% Dauer
Trial 3
% Dauer Average (SD) N
(B) Effects of sgk-1 mutations on daf-2(e1368) dauer formation at 25°C
Wild-type 0.0 0.0 0.0 0 (0) 768
sgk-i(gf) 0.0 0.0 0.0 0 (0) 1007
daf-2(e1368) 81.2 90.7 46.8 72.9 (23.1) 882
daf-2;sgk-1(gf) 83.1 86.8 50.3 73.1 (20.1) 596
Wild-type 0.0 0.0 0.0 0 (0) 1018
sgk-1(null) #1 0.0 0.0 0.0 0 (0) 1498
daf-2(e1368) 87.0 90.8 87.1 88.3 (2.2) 1128
daf-2;sgk-1(null) #1 89.8 95.6 94.3 93.2 (3.0) 1016
Wild-type 0.0 0.0 0.0 0 (0) 861
sgk-1(null) #2 0.0 0.0 0.0 0 (0) 1508
daf-2(e1368) 93.5 90.6 83.2 89.1 (5.3) 1064
daf-2;sgk-1(null) #2 93.2 89.5 88.9 90.5 (2.3) 958
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Cohen, 1999) to Akt/PKB as well as data from mammalian cell culture
(Liu et al., 2000; Brunet et al., 2001) and C. elegans (Hertweck et al.,
2004), Sgk is also thought to inhibit FoxO by promoting its phosphor-
ylation at RxRxxS/T motifs. Our data challenge this model of FoxO
regulation by Sgk and support the notion that in C. elegans, Akt/PKB
and Sgk regulate FoxO activity in fundamentally different ways.
Our conclusions are at oddswith those of the only study in the literature
that has focused on Sgk action in C. elegans lifespan control and FoxO
regulation (Hertweck et al., 2004). This study showed that sgk-1 RNAi
extends lifespan in a DAF-16-/FoxO-dependent manner. One possible
explanation for this discrepancy is that the E. coli strain used for RNAi (the
HB101-related strain HT115) is different from the standard strain used for
growth and maintenance of C. elegans (the E. coli B-related OP50) that
we used in our experiments. Indeed, wild-type C. elegans grown on
HT115 live nearly 20% longer than wild-type animals grown on OP50
(Maier et al., 2010). However, we have shown that sgk-1(null) and sgk-1
(gf) animals are respectively short-lived and long-lived when cultured on
E. coli OP50, HT115, or HB101 (Fig. 1 and Table S1), indicating that the
lifespan phenotypes of sgk-1(null) and sgk-1(gf) are not significantly
influenced by differences between OP50 and HT115/HB101 per se.
We did confirm the previously reported finding that sgk-1 null mutant
animals are thermotolerant compared with wild-type animals (Hertweck
et al., 2004). This suggests that sgk-1 null mutant animals are not
short-lived due to general frailty or sickness, as such animals would be
expected to be generally hypersensitive to environmental stresses.
Intriguingly, daf-16/FoxO was not required for thermotolerance in
sgk-1(null) animals, suggesting that although AKT-1 and SGK-1 both
promote thermosensitivity, they likely do so through distinct mecha-
nisms. Our results dissociate thermotolerance from longevity and
suggest that divergent molecular pathways act downstream of SGK-1
to influence lifespan and responses to increased ambient temperature.
Our results also contrast with a detailed analysis of mammalian FoxO3
regulation demonstrating that both Sgk and Akt/PKB can inhibit FoxO3
activity in cell culture by promoting the phosphorylation of all three
(A) (B)
(C) (D)
(E)
(G)
(F)
Fig. 2 Effects of sgk-1mutations on stress
resistance. (A–F) Stress resistance assays
exposinganimals tohydrogenperoxide (A,B),
UV radiation (C,D), and heat (E,F). Assays
were performed on sgk-1(ok538) (null #1),
sgk-1(mg455) (null #2) (A,C,E), and sgk-1
(ft15) (gf) (B,D,F). (G) Effect of daf-16
(mu86) null mutation on the
thermotolerance of sgk-1 null mutants.
Raw data and statistics are presented in
Tables S2–S4.
sgk-1 mutations and C. elegans lifespan control, A. T.-Y. Chen et al.936
ª 2013 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
conserved sites that lie within RxRxxS/T motifs (Brunet et al., 2001). This
discrepancy may be due in part to differences in experimental context;
these experiments were performed in cell culture, where growth factors
are frequently added in excess of physiologic concentrations, and
overexpressed proteins may exhibit activities that are not discernible
when they are expressed at endogenous levels. The effect of Sgk
knockdown or deletion on the activity of endogenous FoxO transcription
factors has not been investigated in mammals. Although it is conceivable
that Sgk regulates FoxO activity through distinct mechanisms in
mammals and C. elegans, this is unlikely in light of the conservation of
mechanisms of FoxO regulation by insulin-like growth factor signaling
pathways (Kenyon, 2010).
(A)
(D)
(G)
(B)
(E)
(C)
(F)
Fig. 3 Effects of sgk-1 mutations on DAF-16A::GFP subcellular localization and DAF-16/FoxO target gene expression. (A) Subcellular localization of DAF-16A::GFP in akt-1
and sgk-1 mutants. Nuclear localization is increased by akt-1(mg306) null mutation (two-way ANOVA, F = 14.47, P < 0.0001), but not by sgk-1(ok538) null mutation
(F = 1.825, P = 0.1733) or by sgk-1(ft15) gain-of-function mutation (F = 0.869, P = 0.5037). Error bars represent SEM for 3 cohorts of 20–30 animals per genotype
imaged separately. All animals also harbored the daf-16(mu86) null allele, so no endogenous DAF-16/FoxO is present. Representative images are shown in Figure S2. Raw
data and statistics are presented in Table S5. (B,F) Representative experiments measuring sod-3 (B), nnt-1 (C), sip-1 (D), dod-3 (E), and mtl-1 (F) transcript levels using
quantitative RT–PCR on total RNA isolated from young adult animals. Values are normalized to expression levels in wild-type animals. Columns represent mean  SEM of
three technical replicates. Raw data and statistics for biological replicates are summarized in Table S6. (G) Summary of statistically significant gene expression changes
(P < 0.05; Table S6; unpaired two-tailed t-test with Welch’s correction) in akt-1 and sgk-1 mutants and their dependence on DAF-16/FoxO. The asterisk indicates that dod-3
expression was increased significantly in eight of twelve trials. The number sign indicates that daf-16(null) significantly reduced expression of dod-3 and mtl-1 in sgk-1(null)
mutants in five of six trials. See Table S6 for details.
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Although the increased lifespan phenotypes caused by akt-1 null
mutation and the sgk-1(gf) both require daf-16/FoxO (Fig. 1C and Table
S1), the expression of DAF-16/FoxO target genes was influenced by
these two mutations in starkly discordant ways (Fig. 3B–F). Whereas the
expression of five DAF-16/FoxO target genes is induced in a DAF-16/
FoxO-dependent manner in akt-1 null mutants, sgk-1(null) and sgk-1(gf)
mutations had distinct and varying influences on the expression of
specific DAF-16/FoxO target genes. This difference is likely a reflection of
underlying differences in the molecular basis for DAF-16/FoxO regulation
by AKT-1 and SGK-1.
These observations suggest that the underlying mechanisms of
lifespan control by AKT-1 and SGK-1 are fundamentally different. In
contrast to AKT-1, which inhibits DAF-16/FoxO by promoting its
nuclear export and cytoplasmic retention (Hertweck et al., 2004; Zhang
et al., 2008; Alam et al., 2010; Dumas et al., 2010), SGK-1 may
promote longevity by regulating other proteins that functionally and/or
physically interact with DAF-16/FoxO, such as SKN-1 (Tullet et al.,
2008), HSF-1 (Hsu et al., 2003), or HCF-1 (Li et al., 2008). In this
regard, DAF-16/FoxO may play a permissive role in lifespan control by
SGK-1 without being directly regulated by SGK-1. Alternatively, SGK-1
may directly regulate DAF-16/FoxO activity in a small number of cells,
which in turn could control lifespan by influencing other cells in a
DAF-16/FoxO-independent manner.
In summary, we have shown that the AGC kinase family members
Akt/PKB and Sgk control C. elegans lifespan and stress resistance in
fundamentally different ways, and they likely influence FoxO transcrip-
tion factor activity through distinct mechanisms in vivo. Our findings
challenge existing paradigms of FoxO regulation by Sgk and should
engender a reassessment of the role of Sgk in FoxO transcription factor
regulation.
Experimental procedures
Strains and reagents
The following strains were used: N2 Bristol (wild-type), sgk-1(ft15)
(Jones et al., 2009), akt-1(mg306) (Hu et al., 2006), sgk-1(ok538)
(Hertweck et al., 2004), sgk-1(mg455) (Soukas et al., 2009), daf-16
(mu86) (Lin et al., 1997), hcf-1(pk924) (Li et al., 2008), and TJ356
(zIs356) (Henderson & Johnson, 2001). Because sgk-1(ft15) was isolated
after mutagenesis of animals harboring the linked akt-2(tm812) muta-
tion (Jones et al., 2009), we confirmed the absence of akt-2(tm812)
prior to further analysis. Throughout the manuscript, sgk-1(ft15) is
referred to as ‘sgk-1(gf)’, akt-1(mg306) as ‘akt-1(null)’, sgk-1(ok538) as
‘sgk-1(null) #1’, and sgk-1(mg455) as ‘sgk-1(null) #2’. sgk-1 mutant
strains were outcrossed with N2 at least seven times prior to phenotypic
analysis. Wild-type siblings of sgk-1(ft15) from the seventh outcross with
N2 Bristol were used as controls for phenotypic comparison to sgk-1
(ft15). This sibling is labeled ‘wild-type’ in all figures, in contrast to ‘N2
wild-type’. Double and triple mutants were generated using standard
genetic techniques. For maintenance and all assays, animals were grown
in Percival I-30NL or I-36NL incubators (Percival Scientific, Inc., Perry, IA,
USA).
Lifespan assays
Lifespan assays were performed at 20°C as described (Alam et al., 2010;
Dumas et al., 2010). Briefly, animals were treated with alkaline
hypochlorite and grown for at least three generations at 15°C. A
synchronized egg lay was then performed to yield animals for the
lifespan assay. These were grown at 20°C until the L4 larval stage, at
which time they were picked to separate plates and grown until they
were day 2 adults. They were then transferred to NGM plates (10–15
animals per plate) containing 25 lg/mL (100 lM) 5-fluoro-2′-deoxyuri-
dine (FUDR; Sigma-Aldrich, St. Louis, MO, USA) and 10 lg/mL nystatin
(Sigma-Aldrich) and seeded with 209 concentrated OP50. Animals were
incubated at 20°C and scored every 1–2 days. Animals that were not
moving, did not respond to prodding, and did not exhibit pharyngeal
pumping were scored as dead and removed. Animals that died due to
desiccation on the side of the plate, a compromise in vulval integrity, or
bagging were censored. Statistical significance was assessed using the
standard chi-square-based log-rank test in GRAPHPAD PRISM (GraphPad
Software, La Jolla, CA, USA).
Dauer assays
Dauer assays were performed at 25° or 27°C as previously described
(Hu et al., 2006). Briefly, animals were synchronized in a 4- to 6-h egg
lay and grown at 25° or 27°C on NGM plates. Dauers were scored
when wild-type animals were gravid adults and daf-2(e1368) or akt-1
(mg306) mutant animals were arrested as dauers (approximately
60–84 h after egg lay). sgk-1 null mutant animals were plated twelve
hours prior to other strains to compensate for developmental delay.
Plates were observed for two additional days after initial scoring to
account for possible dauer arrest in animals with severe developmental
delay.
Stress resistance assays
Animals were grown at 20°C for 48 hours after a 4- to 6-h egg lay until
most animals were L4 larvae. sgk-1(null) animals were grown starting
12 h earlier than other strains for L4 synchronization due to develop-
mental delay (Hertweck et al., 2004; Jones et al., 2009; Soukas et al.,
2009). Young adults, L3 larvae, and males were removed by suction.
Cohorts were sufficiently large to allow for thermotolerance, oxidative
stress, and UV assays to be performed in parallel. All assays were
performed in triplicate.
For oxidative stress assays, L4 larvae were transferred to fresh seeded
NGM plates, grown for an additional 18 h, washed two or three times
with M9 buffer, and diluted to a concentration of ~ 50 animals mL1 of
M9. 0.5 mL of animals was dispensed to Eppendorf tubes and rocked for
~ 20 min to allow animals to digest E. coli. Four tubes were used per
genotype per concentration of H2O2. 0.5 mL of H2O2 dissolved in M9
was then added to each tube to the final concentration, followed by
rocking for 2 h protected from light. The H2O2 solution was then
removed, and the animals were washed with M9. Animals were then
pipetted back onto fresh NGM plates and scored after an 18-h recovery
period at 20°C. Two-way ANOVA was conducted using GraphPad Prism,
with survival of animals on each plate as the dependent variable and
H2O2 dose and genotype as independent variables.
UV stress assays were performed as described (Wolff et al., 2006).
Briefly, animals were transferred to plates containing 25 lg mL1 FUDR
on day 1 of adulthood. After four days, they were transferred to plates
lacking bacteria and irradiated with 1200 J m2 UV-C using a Strata-
linker 2400 UV crosslinker (Stratagene, La Jolla, CA, USA). They were
then transferred onto NGM plates with food and scored daily for
survival. Statistical significance was assessed using the standard
chi-square-based log-rank test.
Thermotolerance assays were performed essentially as described
(Kwon et al., 2010). Briefly, L4 larvae were transferred to fresh seeded
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NGM plates (~20 per plate) and then grown for an additional 18 h
prior to shifting them to an incubator set at 35°C. Four plates were
used per genotype per time point. At each time point, plates to be
scored were removed and incubated further for 18 h at 20°C, after
which living and dead animals were scored. Two-way ANOVA was
conducted using GRAPHPAD PRISM, with survival of animals on each
plate as the dependent variable and time at 35°C and genotype as
independent variables.
DAF-16A::GFP localization assays
Animals were mounted onto slides in M9 with 10 mM sodium azide.
Approximately ten young adults were picked to each slide, and the
anterior segment of each animal was imaged within five minutes after
mounting. Images were scored according to the criteria shown in
Figure S1. Both imaging and scoring were performed in a blinded
fashion. Two-way ANOVA was used to assess statistical significance in
GRAPHPAD PRISM.
Quantitative RT–PCR
Animals from a 4.5-h egg lay were grown at 20°C for 48 h until most
animals were L4 larvae. sgk-1(null) animals were grown starting 12 h
earlier than other strains for L4 synchronization due to developmental
delay (Hertweck et al., 2004; Jones et al., 2009; Soukas et al., 2009).
Young adults and L3 larvae were removed by suction, and the remaining
animals were grown for an additional 12 h. Total RNA was isolated from
600–1000 young adults per strain per biological replicate using TRIzol
(Invitrogen, Carlsbad, CA, USA) and purified using an RNeasy Kit
(QIAGEN Inc., Valencia, CA, USA). cDNA was synthesized using a
Superscript III Reverse Transcriptase Kit (Invitrogen). SYBR Green (Applied
Biosystems, Warrington, UK) Real-Time PCR was then performed using
primers corresponding to the DAF-16/FoxO target genes sod-3, nnt-1,
sip-1, dod-3, and mtl-1. act-1 was used as an internal control.
Quantitative PCR primer sequences are listed in Table S7. Statistical
analysis was performed in GraphPad Prism by unpaired two-tailed t-test
with Welch’s correction.
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